Our data showed that HVEM expression was significantly downregulated on circulating CD8+ T cells in HCC patients, while appreciable difference in BTLA expression was absent (Figures 1(b) and 2(b)). The gene discussed is TNFRSF14; the disease is hepatocellular carcinoma.